Pharmaceutical management of arterial hypertension comorbid with metabolic disorders

dc.contributor.author	Strechen, S. B.
dc.contributor.author	Hiraji, R.
dc.date.accessioned	2025-06-30T11:40:52Z
dc.date.available	2025-06-30T11:40:52Z
dc.date.issued	2024
dc.identifier.citation	Strechen S. B., Hiraji R. Pharmaceutical management of arterial hypertension comorbid with metabolic disorders. Фармакологія та лікарська токсикологія. 2024. Т. 18, № 3. С. 236–237.	uk_UA
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/17879
dc.description.abstract	The study involved a retrospective analysis of medical records for outpatients and inpatients. both male and female. with stage II-III hypertension of medium and high risk. combined with coronary heart disease, type 2 diabetes, systematic atherosclerosis, hyperuricemia and obesity.	uk_UA
dc.language.iso	en	uk_UA
dc.subject	II-III hypertension	uk_UA
dc.subject	type 2 diabetes	uk_UA
dc.subject	systematic atherosclerosis	uk_UA
dc.title	Pharmaceutical management of arterial hypertension comorbid with metabolic disorders	uk_UA
dc.type	Article	uk_UA